Share Boardroom Media
Share to email
Share to Facebook
Share to X
Grant Thornton is one of the world's leading organisations for independent assurance, tax and advisory. Today Boardroom.Media Reporter Velvet-Belle Templeman speaks to Luke Ritchie, Partner & National Head of Retail and Consumer Products at Grant Thornton Australia about the implications of Covid-19 on the Australian discretionary retail market.
Grant Thornton is one of the world's leading organisations for independent assurance, tax and advisory. Today Boardroom.Media Reporter Velvet-Belle Templeman speaks to Tony Markwell, National Managing
Partner of Private Advisory at Grant Thornton. They talk about the light at the end of the COVID-19 tunnel, and how we can harness culture and innovation to do things differently in the ‘new normal’.
Grant Thornton is one of the world's leading organisations for independent assurance, tax and advisory. Today Boardroom.Media Reporter Velvet-Belle Templeman speaks to Madeleine Mattera, National Head of Financial Services at Grant Thornton. They discuss the current COVID-19 crisis and the role of the Financial Services sector in supporting the economy.
Grant Thornton is one of the world's leading organisations of independent assurance, tax and advisory firms. Today Boardroom.Media Reporter Velvet-Belle Templeman speaks to Said Jahani, National Managing Partner - Financial Advisory of Grant Thornton. They discuss COVID-19: how it’s impacting the business world, how various sectors are dealing with the impacts, and how they should be preparing.
Holista CollTech (ASX: HCT) today announced that it has filed its 100%-owned global patent for platform technology that will deliver many fat-soluble medications by creating a water-soluble delivery system. This patented process can apply to a whole range of molecules including the Cannabidiol (CBD) oil industry.
Openpay Group Ltd (OPY) is a payments technology company that offers a buy now, pay later (BNPL) product and is headquartered in Melbourne, Australia. Openpay provides a payments platform that facilitates seamless, secure and swift payments between Customers and Merchants. The Openpay platform allows Customers to make in-store and online purchases, and effectively split the payment for these purchases into multiple repayments over time, while attracting no interest.
Business Journalist Velvet-Belle Templeman speaks to Paul Hopper, the Executive Chairman of SUDA Pharmaceuticals Ltd (ASX: SUD). The company, a leader in oro-mucosal drug delivery, announced that it has entered into a fully-funded feasibility study and option agreement with Spanish pharmaceutical company Laboratorios Ordesa, S.L., (Ordesa). Hopper discusses product commercialisation, exciting developments in their Cancer project, the role of the company's new CEO as well as insights for shareholders in the next 6 months.
Regeneus Ltd (ASX: RGS) a clinical-stage regenerative medicine company, has come to a mutual agreement with Japan-based manufacturer AGC Inc (AGC) to terminate their exclusive manufacturing licence and joint venture agreement.
As the U.S. prepares to pass the historic US Farm Bill, which includes the legalisation of industrial hemp, Elixinol Global CEO Paul Benhaim discusses the implications for the business and how the legislation change will support the company’s plans to expand its market operations.
Medlab Clinical Ltd (ASX: MDC) remains uniquely positioned as a fundamentally corner-stoned company in medical research but increasingly delivering a successful path to commercialisation in its Nutraceutical and Cannabis based products.
The podcast currently has 21 episodes available.